Campine (CAMB) - Net Assets
Based on the latest financial reports, Campine (CAMB) has net assets worth €136.30 Million EUR (≈ $159.35 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€243.99 Million ≈ $285.25 Million USD) and total liabilities (€107.69 Million ≈ $125.90 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Campine's equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €136.30 Million |
| % of Total Assets | 55.86% |
| Annual Growth Rate | 9.98% |
| 5-Year Change | 184.11% |
| 10-Year Change | 610.36% |
| Growth Volatility | 18.51 |
Campine - Net Assets Trend (2000–2025)
This chart illustrates how Campine's net assets have evolved over time, based on quarterly financial data. See CAMB cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Campine (2000–2025)
The table below shows the annual net assets of Campine from 2000 to 2025. For live valuation and market cap data, see how much is Campine worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €136.30 Million ≈ $159.35 Million |
+57.17% |
| 2024-12-31 | €86.72 Million ≈ $101.38 Million |
+25.42% |
| 2023-12-31 | €69.14 Million ≈ $80.84 Million |
+16.11% |
| 2022-12-31 | €59.55 Million ≈ $69.62 Million |
+24.13% |
| 2021-12-31 | €47.97 Million ≈ $56.09 Million |
+35.09% |
| 2020-12-31 | €35.51 Million ≈ $41.52 Million |
+0.06% |
| 2019-12-31 | €35.49 Million ≈ $41.49 Million |
+20.19% |
| 2018-12-31 | €29.53 Million ≈ $34.52 Million |
+20.12% |
| 2017-12-31 | €24.58 Million ≈ $28.74 Million |
+28.12% |
| 2016-12-31 | €19.19 Million ≈ $22.43 Million |
-18.28% |
| 2015-12-31 | €23.48 Million ≈ $27.45 Million |
+3.90% |
| 2014-12-31 | €22.60 Million ≈ $26.42 Million |
+4.27% |
| 2013-12-31 | €21.67 Million ≈ $25.34 Million |
-5.40% |
| 2012-12-31 | €22.91 Million ≈ $26.79 Million |
-16.08% |
| 2011-12-31 | €27.30 Million ≈ $31.92 Million |
+6.86% |
| 2010-12-31 | €25.55 Million ≈ $29.87 Million |
+29.05% |
| 2009-12-31 | €19.80 Million ≈ $23.15 Million |
-8.84% |
| 2008-12-31 | €21.72 Million ≈ $25.39 Million |
-8.38% |
| 2007-12-31 | €23.71 Million ≈ $27.71 Million |
+22.49% |
| 2006-12-31 | €19.35 Million ≈ $22.63 Million |
+15.08% |
| 2005-12-31 | €16.82 Million ≈ $19.66 Million |
-1.42% |
| 2004-12-31 | €17.06 Million ≈ $19.94 Million |
+40.25% |
| 2003-12-31 | €12.16 Million ≈ $14.22 Million |
+0.85% |
| 2002-12-31 | €12.06 Million ≈ $14.10 Million |
+8.71% |
| 2001-12-31 | €11.10 Million ≈ $12.97 Million |
-12.22% |
| 2000-12-31 | €12.64 Million ≈ $14.78 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Campine's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 13229700000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €132.30 Million | 97.07% |
| Common Stock | €4.00 Million | 2.93% |
| Total Equity | €136.30 Million | 100.00% |
Campine Competitors by Market Cap
The table below lists competitors of Campine ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
$330.04 Million |
|
BlackRock California Municipal Income Closed Fund
NYSE:BFZ
|
$330.10 Million |
|
Novabase SGPS
LS:NBA
|
$330.11 Million |
|
Kamada
TA:KMDA
|
$330.32 Million |
|
Radiant Logistics Inc
NYSE MKT:RLGT
|
$329.99 Million |
|
El Pollo Loco Holdings Inc
NASDAQ:LOCO
|
$329.95 Million |
|
AB Traction
ST:TRAC-B
|
$329.91 Million |
|
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
|
$329.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Campine's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 86,719,000 to 136,297,000, a change of 49,578,000 (57.2%).
- Net income of 56,624,000 contributed positively to equity growth.
- Dividend payments of 6,855,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €56.62 Million | +41.54% |
| Dividends Paid | €6.86 Million | -5.03% |
| Other Changes | €-191.00K | -0.14% |
| Total Change | €- | 57.17% |
Book Value vs Market Value Analysis
This analysis compares Campine's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.44x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 19.52x to 2.44x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €11.37 | €222.00 | x |
| 2005-12-31 | €11.21 | €222.00 | x |
| 2006-12-31 | €12.90 | €222.00 | x |
| 2007-12-31 | €15.80 | €222.00 | x |
| 2008-12-31 | €14.48 | €222.00 | x |
| 2009-12-31 | €13.20 | €222.00 | x |
| 2010-12-31 | €17.03 | €222.00 | x |
| 2011-12-31 | €18.20 | €222.00 | x |
| 2012-12-31 | €15.27 | €222.00 | x |
| 2013-12-31 | €14.45 | €222.00 | x |
| 2014-12-31 | €15.07 | €222.00 | x |
| 2015-12-31 | €15.65 | €222.00 | x |
| 2016-12-31 | €12.79 | €222.00 | x |
| 2017-12-31 | €16.39 | €222.00 | x |
| 2018-12-31 | €19.69 | €222.00 | x |
| 2019-12-31 | €23.66 | €222.00 | x |
| 2020-12-31 | €23.67 | €222.00 | x |
| 2021-12-31 | €31.98 | €222.00 | x |
| 2022-12-31 | €39.70 | €222.00 | x |
| 2023-12-31 | €46.10 | €222.00 | x |
| 2024-12-31 | €57.81 | €222.00 | x |
| 2025-12-31 | €90.86 | €222.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Campine utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 41.54%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.39%
- • Asset Turnover: 3.14x
- • Equity Multiplier: 1.79x
- Recent ROE (41.54%) is above the historical average (13.99%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 12.50% | 2.75% | 1.69x | 2.69x | €316.00K |
| 2002 | 11.64% | 2.53% | 1.66x | 2.78x | €197.90K |
| 2003 | 10.23% | 2.17% | 2.03x | 2.33x | €27.70K |
| 2004 | 17.53% | 4.37% | 1.90x | 2.11x | €1.29 Million |
| 2005 | 18.42% | 4.20% | 1.87x | 2.35x | €1.42 Million |
| 2006 | 23.37% | 4.50% | 1.81x | 2.87x | €2.59 Million |
| 2007 | 26.97% | 5.02% | 1.81x | 2.97x | €4.02 Million |
| 2008 | 4.88% | 1.06% | 2.23x | 2.06x | €-1.11 Million |
| 2009 | -5.66% | -1.39% | 1.77x | 2.31x | €-3.10 Million |
| 2010 | 22.51% | 4.18% | 1.91x | 2.81x | €3.20 Million |
| 2011 | 14.84% | 2.23% | 2.25x | 2.96x | €1.32 Million |
| 2012 | -10.76% | -1.64% | 2.09x | 3.13x | €-4.76 Million |
| 2013 | -5.28% | -0.83% | 2.52x | 2.52x | €-3.31 Million |
| 2014 | 4.00% | 0.60% | 2.59x | 2.57x | €-1.35 Million |
| 2015 | 4.07% | 0.58% | 3.02x | 2.31x | €-1.39 Million |
| 2016 | -19.86% | -2.23% | 2.53x | 3.52x | €-5.73 Million |
| 2017 | 28.51% | 3.24% | 3.00x | 2.94x | €4.55 Million |
| 2018 | 19.74% | 2.77% | 3.42x | 2.09x | €2.88 Million |
| 2019 | 22.58% | 4.16% | 3.33x | 1.63x | €4.47 Million |
| 2020 | 7.84% | 1.67% | 2.60x | 1.81x | €-767.10K |
| 2021 | 28.16% | 5.97% | 2.44x | 1.93x | €8.71 Million |
| 2022 | 26.54% | 4.98% | 2.49x | 2.14x | €9.85 Million |
| 2023 | 19.74% | 4.24% | 2.56x | 1.82x | €6.74 Million |
| 2024 | 25.67% | 6.10% | 2.33x | 1.81x | €13.59 Million |
| 2025 | 41.54% | 7.39% | 3.14x | 1.79x | €42.99 Million |
Industry Comparison
This section compares Campine's net assets metrics with peer companies in the Waste Management industry.
Industry Context
- Industry: Waste Management
- Average net assets among peers: $1,921,757,000
- Average return on equity (ROE) among peers: -77.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Campine (CAMB) | €136.30 Million | 12.50% | 0.79x | $330.00 Million |
| Umicore S.A. (UMI) | $1.92 Billion | -77.01% | 3.90x | $4.80 Billion |
About Campine
Campine NV engages in the circular metals and specialty chemicals businesses in Belgium and internationally. The company produces and sells lead and lead alloys; recovers, treats, and refines lead, tin, precious metals, and antimony to produce new and reusable raw materials; and offers recycled batteries. It also manufactures antimony trioxide used as flame retardants, polymerization catalysts, a… Read more